DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company,
DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company, located in Birmingham, AL, formed with the ultimate goal of integrating human cell physiology with the drug discovery critical path. DBM’s founder, Erik Schwiebert, Ph.D., a physiologist by trade, launched the company in October 2007 and closed on seed capital investment with Greer Capital Advisors in November of 2007 (Birmingham Technology Fund). Since then DBM has continued to grow and gain recognition both locally and nationally.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 8, 2015 | Grant | $1.61M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | — | Grant |